Journal of Antimicrobial Chemotherapy (1999) 43, 261-266
© 1999 The British Society for Antimicrobial Chemotherapy
The control of hyperendemic glycopeptide-resistant Enterococcus spp. on a haematology unit by changing antibiotic usage
a Department of Clinical Microbiology, University College London Hospitals, London, WC1E 6DB b Department of Haematology, University College London Hospitals, London, WC1E 6DB; c Wyeth UK Ltd, Maidenhead, Berks, SL6 0PH, UK
The rectal carriage of glycopeptide-resistant Enterococcus spp. (GRE) had been established at approximately 50% in a series of prevalence studies on a busy haematological malignancy unit. The aim of this study was to reduce the chance of patients acquiring GRE. A prospective three-phase sequential study was performed. In Phase 1, the acquisition rate of GRE detectable by rectal swab was measured without any intervention for a period of 4 months. For the following 8 months (Phase 2), the first-line treatment for febrile neutropenic episodes was changed from monotherapy with ceftazidime to piperacillin/tazobactam. In addition, an intense education programme was introduced to improve hygiene to reduce the risk of case-to-case spread. In the final 4 months (Phase 3), ceftazidime was again used as the first-line antimicrobial, while continuing the same level of training in relation to hygiene. The carriage of GRE was measured from rectal swabs done weekly. During the initial 4 months, at any time, 40-50% of patients in the unit were colonized with GRE, and 43 of 75 (57%) new patients initially negative for GRE acquired it within 6 weeks of their admission. In Phase 2, 25 patients out of 129 (19%) acquired GRE, with the acquisition rate falling progressively so that in the last 3 months, only one new patient acquired GRE (logrank comparison of probabilities for cohort 1 vs cohort 2b: P < 0.0001). A return to ceftazidime in Phase 3 was associated with a return of the risk of acquiring detectable GRE colonization, despite continued hygiene teaching and surveillance, with 21 out of 58 patients (36%) acquiring GRE (cohort 1 vs cohort 3: P= 0.08). Glycopeptide usage was not reduced during the period of the study. Clinical cases were seen only in Phases 1 and 3. Although the reduction in the risk of acquiring GRE may have been due in part to hygiene practices as well as to the change in antimicrobial usage, or may have occurred spontaneously for other reasons, the return of the problem with the reintroduction of ceftazidime strongly suggests that this antibiotic was responsible for encouraging the acquisition of detectable GRE.
* Correspondence address. Department of Clinical Microbiology, University College London Hospitals, Grafton Way, London WC1E 6DB. Tel:+44-171-380-9914; Fax:+44-171-388-8514.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  B. S. Cooper, G. F. Medley, S. J. Bradley, and G. M. Scott An Augmented Data Method for the Analysis of Nosocomial Infection Data Am. J. Epidemiol., September 1, 2008; 168(5): 548 - 557. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Paterson, C. A. Muto, M. Ndirangu, P. K. Linden, B. A. Potoski, B. Capitano, R. A. Bonomo, D. C. Aron, and C. J. Donskey Acquisition of Rectal Colonization by Vancomycin-Resistant Enterococcus among Intensive Care Unit Patients Treated with Piperacillin-Tazobactam versus Those Receiving Cefepime-Containing Antibiotic Regimens Antimicrob. Agents Chemother., February 1, 2008; 52(2): 465 - 469. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Sandiumenge, E. Diaz, A. Rodriguez, L. Vidaur, L. Canadell, M. Olona, M. Rue, and J. Rello Impact of diversity of antibiotic use on the development of antimicrobial resistance J. Antimicrob. Chemother., June 1, 2006; 57(6): 1197 - 1204. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. H. Tam, S. Adams, M. T. Larocco, L. N. Gerard, L. O. Gentry, and K. W. Garey An integrated pharmacoeconomic approach to antimicrobial formulary decision-making Am. J. Health Syst. Pharm., April 15, 2006; 63(8): 735 - 739. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. R. Peterson and K. Singh Universal Patient Disinfection as a Tool for Infection Control: Rub-A-Dub-Dub, No Need for a Tub Arch Intern Med, February 13, 2006; 166(3): 274 - 276. [Full Text] [PDF]
|
|
|
|
|
|
C. Martin, I. Ofotokun, R. Rapp, K. Empey, J. Armitstead, C. Pomeroy, A. Hoven, and M. Evans Results of an antimicrobial control program at a university hospital Am. J. Health Syst. Pharm., April 1, 2005; 62(7): 732 - 738. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Brown and D. Nathwani Antibiotic cycling or rotation: a systematic review of the evidence of efficacy J. Antimicrob. Chemother., January 1, 2005; 55(1): 6 - 9. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. G. Masterton Antibiotic cycling: more than it might seem? J. Antimicrob. Chemother., January 1, 2005; 55(1): 1 - 5. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Ramsay, E. Brown, G. Hartman, P. Davey, and on behalf of the joint BSAC/HIS Working Party on O Room for improvement: a systematic review of the quality of evaluations of interventions to improve hospital antibiotic prescribing J. Antimicrob. Chemother., November 1, 2003; 52(5): 764 - 771. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Martinez, R. Ruthazer, K. Hansjosten, L. Barefoot, and D. R. Snydman Role of Environmental Contamination as a Risk Factor for Acquisition of Vancomycin-Resistant Enterococci in Patients Treated in a Medical Intensive Care Unit Arch Intern Med, September 8, 2003; 163(16): 1905 - 1912. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. B. R. Ferreira, N. L. P. Iorio, K. L. Malvar, A. P. F. Nunes, L. S. Fonseca, C. C. R. Bastos, and K. R. N. Santos Coagulase-Negative Staphylococci: Comparison of Phenotypic and Genotypic Oxacillin Susceptibility Tests and Evaluation of the Agar Screening Test by Using Different Concentrations of Oxacillin J. Clin. Microbiol., August 1, 2003; 41(8): 3609 - 3614. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Harbarth, S. Cosgrove, and Y. Carmeli Effects of Antibiotics on Nosocomial Epidemiology of Vancomycin-Resistant Enterococci Antimicrob. Agents Chemother., June 1, 2002; 46(6): 1619 - 1628. [Full Text] [PDF]
|
|
|
|
|
|
S. J. Dancer The problem with cephalosporins J. Antimicrob. Chemother., October 1, 2001; 48(4): 463 - 478. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. F. Kennedy, C. G. Gemmell, J. Bagg, B. E. S. Gibson, and J. R. Michie Antimicrobial susceptibility of blood culture isolates of viridans streptococci: relationship to a change in empirical antibiotic therapy in febrile neutropenia J. Antimicrob. Chemother., May 1, 2001; 47(5): 693 - 696. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Patterson Antibiotic Utilization : Is There an Effect on Antimicrobial Resistance? Chest, February 1, 2001; 119 (2009): 426S - 430S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. L. S. Lee, K. Y. Yuen, and C. R. Kumana {beta}-Lactam Antibiotic and {beta}-Lactamase Inhibitor Combinations JAMA, January 24, 2001; 285(4): 386 - 388. [Full Text] [PDF]
|
|
|
|
 |
|
 B. E. Murray Vancomycin-Resistant Enterococcal Infections N. Engl. J. Med., March 9, 2000; 342(10): 710 - 721. [Full Text] [PDF]
|
|